Company Directory

Company Directory

Company Directory - IQVIA

Company Details - IQVIA

IQVIA Logo

IQVIA

IQVIA provides advanced analytics, technology solutions, and contract research services to the healthcare industry.

CCI Score

CCI Score: IQVIA

14.26

-0.01%

Latest Event

Revolving Door Concerns in IQVIA Lobbying

OpenSecrets data reveals that a significant portion of IQVIA's lobbyists—7 out of 10 in 2023 and 6 out of 12 in 2024—are former government officials. This revolving door raises concerns about potential regulatory capture and undue political influence in policymaking.

Take Action

So what can you do? Support by shopping, spreading the word, or offering your support.

Shop Alternatives
SEE ALL
Use Your Voice
OTHER TOOLS
Investigate
Share the Score
SUPPORT CCI

SABOTEUR

IQVIA is currently rated as a Saboteur.

+10 to +24 CCI Score
Companies in this bracket take more subtle actions to undermine authoritarian practices. They might implement internal policies or support reforms that quietly weaken oppressive systems, contributing to change in less overt ways.

Latest Events

  • Revolving Door Concerns in IQVIA Lobbying Logo
    FEB
    19
    2025

    OpenSecrets data reveals that a significant portion of IQVIA's lobbyists—7 out of 10 in 2023 and 6 out of 12 in 2024—are former government officials. This revolving door raises concerns about potential regulatory capture and undue political influence in policymaking.

  • -40

    Executive Political Engagement

    March 28

    The reliance on ex-government officials as lobbyists indicates a problematic level of executive political engagement. This practice can blur the lines between public service and private influence, undermining transparent democratic processes.

    IQVIA Profile: Summary • OpenSecrets

  • -30

    Regulatory Capture

    March 28

    The revolving door between government and IQVIA's lobbying efforts also raises the specter of regulatory capture. This can result in policies that favor corporate interests over the public good, thereby increasing the company's complicity in undermining transparent governance.

    IQVIA Profile: Summary • OpenSecrets

  • Anti-Slavery & Human Trafficking Statement 2023 Logo
    NOV
    26
    2024

    IQVIA published its comprehensive Anti-Slavery & Human Trafficking Statement for the financial year ending December 31, 2023, approved by the boards on November 26, 2024. The statement outlines robust policies, including a Code of Conduct, Supplier Code of Conduct, and mandatory ethics and compliance training aimed at preventing modern slavery and human trafficking throughout its global operations and supply chain.

  • +80

    Labor Relations and Human Rights Practices

    March 28

    IQVIA's statement demonstrates a proactive approach toward labor rights by outlining comprehensive anti-slavery measures, robust internal policies, and mandatory training. Such measures strengthen human rights practices and support worker protection, especially within the high-skill, regulated work environments present at IQVIA.

    Anti-Slavery & Human Trafficking Statement - IQVIA

  • +75

    Supply Chain Ethics

    March 28

    By implementing a Supplier Code of Conduct and setting high expectations for suppliers regarding human rights and ethical practices, IQVIA strengthens accountability and transparency in its supply chain, thereby reducing risks tied to modern slavery and human trafficking.

    Anti-Slavery & Human Trafficking Statement - IQVIA

  • IQVIA Issues Anti-Slavery & Human Trafficking Statement Logo
    NOV
    26
    2024

    IQVIA released an anti-slavery and human trafficking statement for the financial year ending December 31, 2023, approved by the boards on November 26, 2024. The statement outlines robust measures including a comprehensive Code of Conduct, strict supplier requirements, mandatory training, and multiple compliance channels to prevent modern slavery and human trafficking.

  • +80

    Labor Relations and Human Rights Practices

    March 28

    IQVIA’s detailed statement underscores a strong commitment to labor rights and human rights by instituting rigorous internal policies, clear employee training, and transparent reporting mechanisms. This approach helps safeguard workers and aligns with anti-slavery best practices.

    Anti-Slavery & Human Trafficking Statement - IQVIA

  • +75

    Supply Chain Ethics

    March 28

    The statement also places strong emphasis on supply chain ethics, requiring suppliers to adhere to high human rights standards. The Supplier Code of Conduct and periodic evaluations reflect IQVIA's proactive stance in ensuring ethical practices beyond their immediate operations.

    Anti-Slavery & Human Trafficking Statement - IQVIA

  • IQVIA Publishes 2023 ESG Report Logo
    FEB
    26
    2024

    IQVIA published its 2023 Environmental, Social and Governance Report, highlighting its commitment to sustainability, public health, and robust privacy protections amid a challenging macro-environment.

  • +70

    Business Practices and Ethical Responsibility

    March 28

    IQVIA’s ESG report demonstrates a strong commitment to transparency and ethical business practices by detailing its sustainability efforts, social responsibility initiatives, and focus on public health, which aligns with progressive corporate values.

    IQVIA Publishes its 2023 Environmental, Social and Governance Report

  • +60

    Technology and Services Impact

    March 28

    The publication emphasizes the role of advanced analytics and technology in safeguarding patient privacy and enhancing healthcare outcomes, underscoring IQVIA's adherence to ethical technology practices.

    IQVIA Publishes its 2023 Environmental, Social and Governance Report

  • IQVIA Releases 2023 ESG Report Highlighting Sustainability and Privacy Protections Logo
    FEB
    26
    2024

    IQVIA published its 2023 Environmental, Social and Governance Report, outlining its commitment to reducing its environmental impact, advancing public health outcomes, and safeguarding patient privacy through advanced, privacy-enhancing technologies.

  • +60

    Business Practices and Ethical Responsibility

    March 28

    The ESG report demonstrates IQVIA’s strong commitment to ethical business practices by detailing its sustainability efforts and positive contributions to public health, which align with robust social responsibility and labor practices.

    IQVIA Publishes its 2023 Environmental, Social and Governance Report

  • +30

    Technology and Services Impact

    March 28

    IQVIA’s emphasis on protecting individual patient privacy through the use of advanced, privacy-enhancing technologies in its ESG report reflects a positive impact on technology and services, mitigating risks associated with surveillance or data misuse.

    IQVIA Publishes its 2023 Environmental, Social and Governance Report

  • IQVIA Releases 2023 ESG Report Logo
    FEB
    26
    2024

    IQVIA published its 2023 Environmental, Social and Governance Report on February 26, 2024, outlining its commitments to improved business practices and corporate transparency. While the report details were not extensively covered in the article, its publication is viewed as a positive step toward ensuring greater accountability and ethical responsibility.

  • +20

    Business Practices and Ethical Responsibility

    March 28

    Publishing an ESG report can be seen as a step toward greater transparency and improved business practices. Although the article does not provide detailed assurances regarding labor or diversity initiatives, the release of the report indicates an effort to address environmental, social, and governance issues in a structured manner, which aligns with anti-authoritarian and ethical business practices.

    IQVIA Publishes its 2023 Environmental, Social and Governance Report

  • IQVIA 2023 Lobbying Expenditure Logo
    DEC
    31
    2023

    IQVIA spent $690,000 on lobbying activities in 2023, as reported by OpenSecrets, highlighting its investment in influencing U.S. political processes.

  • -40

    Political Contributions and Lobbying Efforts

    March 28

    IQVIA's reported $690,000 expenditure on lobbying in 2023 raises concerns about corporate influence over public policy, reinforcing power imbalances that can undermine democratic accountability. From an anti-fascist perspective, such expenditure is seen as aligning corporate interests with political establishment efforts that may stifle progressive reforms.

    IQVIA Lobbying Profile • OpenSecrets

  • IQVIA Lobbying Expenditure in 2023 Logo
    DEC
    31
    2023

    IQVIA spent $690,000 on federal lobbying activities during 2023, as detailed by OpenSecrets. This expenditure raises concerns about corporate influence in political processes.

  • -30

    Political Contributions and Lobbying Efforts

    March 28

    IQVIA’s reported $690,000 in lobbying spending for 2023 indicates a significant investment in influencing political processes. From an anti-fascist perspective, such expenditures can be seen as efforts to secure favorable policies and dampen democratic accountability, potentially aligning with corporate interests that undermine broad-based public participation in governance.

    IQVIA Lobbying Profile • OpenSecrets

  • IQVIA Lobbying Activity Logo
    JAN
    01
    2023

    IQVIA's profile on OpenSecrets details its long-running lobbying activities, including annual totals since 1998 and data on bills lobbied in 2023, highlighting the company's engagement in influencing public policy.

  • -50

    Political Contributions and Lobbying Efforts

    March 28

    IQVIA's sustained investment in lobbying, as evidenced by its OpenSecrets profile, indicates active engagement in influencing legislative processes. Such corporate political activities can undermine democratic accountability and prioritize corporate interests over public welfare, raising concerns from an anti-authoritarian perspective.

    IQVIA Profile: Lobbying • OpenSecrets

Industries

541519
Other Computer Related Services
541611
Administrative Management and General Management Consulting Services
541712
Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)